A comprehensive view of Perrigo PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Perrigo's Opill, the first daily birth control pill available without a prescription in the US, begins shipping to retailers nationwide and online pre-orders open; manufacturer's suggested retail price at set at US$19.99 to US$49.99

Opill, the first OTC birth control pill approved in the US, is set to be launched by Perrigo in Q1 2024; many states are enacting laws that enable pharmacists to prescribe birth control without a doctor's prescription, with 29 states already allowing this

Packaging for Perrigo’s Opill, the first OTC birth control pill to be sold in US, features bright teal, saturated pink and yellow, plus a rounded font reminiscent of Gotham; design is intended to set product apart from prescription contraceptive pills

Perrigo recalls certain lots of Gerber Good Start SoothePro Powdered Infant Formula in the US because of potential cronobacter sakazakii contamination

FDA panel backs OTC sales of Perrigo's Opill contraceptive pill; ruling comes despite criticisms from some FDA scientists who voiced concerns about how Perrigo studied the drug

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count